The Human Cancer PrimaCell™ 1: Esophageal Tumor Cells is for rapid (7-10 days) isolation and growth of human esophageal tumor cells from human esophageal tumor tissues. This system features an optimal condition of tissue dissociation system, Cancer OptiTDS™ that yields 5-7 times of single cells more than most of the tissue dissociation protocols published in the literature. In addition, this system ensures a high viability of the target cells with improved gradient contained in the culture medium.

Human Cancer PrimaCell™ 1 System (Cat No. 2-96024):
Human Cancer PrimaCell™ 1: Esophageal Tumor Cells Protocols
Human Cancer Tissue Preparation Buffer 1: Esophageal Tumor Cells
Human Cancer OptiTDS™ 1: Tissue Dissociation System
Human Cancer PrimaCell™ 1: Esophageal Tumor Cells Growth Medium
Human Cancer PrimaCell™ 1: Esophageal Tumor Cells Growth Supplements with Serum (for 500 ml medium)

References:

[1] Miao Kim MS, Chang X, LeBron C, Nagpal JK, Lee J, Huang Y, Yamashita K, Trink B, Ratovitski EA, Sidransky D Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma. PLoS One. 2010 Feb 3;5(2):e9003.
[2] Watson GA, Queiroz de Oliveira PE, Stang MT, Armstrong MJ, Gooding WE, Kuan SF, Yim JH, Hughes SJ. Ad-IRF-1 induces apoptosis in esophageal adenocarcinoma. Neoplasia. 2006 Jan;8(1):31-7.
[3] Zhang H, Jin Y, Chen X, Jin C, Law S, Tsao SW, Kwong YL. Cytogenetic aberrations in immortalization of esophageal epithelial cells. Cancer Genet Cytogenet. 2006 Feb;165(1):25-35.